16 results
10-Q
2023 Q3
EX-3.1
TRML
Tourmaline Bio Inc
Quarterly report
14 Nov 23
5:12pm
8-K
EX-3.1
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.2
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.3
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
S-4
EX-3.2
TRML
Tourmaline Bio Inc
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.3
0n0mu6 18h4l
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.1
304prgm3zuzmlns0gg
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
8-K
EX-3.1
llakbwzp9 4ixv6yj
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-3.2
lvloysc 2b
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
S-1/A
EX-3.1
sn79d0mkws3
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
9osbxuzorhl4hoo3zall
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.2
ekk233dmv4
3 May 21
IPO registration (amended)
6:07am
S-1
EX-3.3
57kvryrz
16 Apr 21
IPO registration
5:03pm
S-1
EX-3.1
fn76o8tf2
16 Apr 21
IPO registration
5:03pm
DRS
EX-3.3
35ffpdje hx
26 Feb 21
Draft registration statement
12:00am
DRS
EX-3.1
9dm7zp3p7mo
26 Feb 21
Draft registration statement
12:00am
- Prev
- 1
- Next